SpringWorks Therapeutics and Jewelry Designer Jennifer Fisher Team Up to Encourage People with Desmoid Tumors to Take Action Before Their Tumor Takes Over

Core Insights - SpringWorks Therapeutics is collaborating with Jennifer Fisher to raise awareness about desmoid tumors and encourage patients to seek specialized care [1][3][4] Company Overview - SpringWorks Therapeutics is a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, having developed the first FDA-approved therapy for adults with progressing desmoid tumors [6][7] Industry Context - Desmoid tumors are rare, aggressive, and locally invasive soft tissue tumors, with an estimated 1,000-1,650 new cases diagnosed annually in the United States [5][6] - The tumors have a high recurrence rate of up to 77% after surgical resection, leading to a shift in treatment guidelines recommending systemic therapies as the first-line intervention [5][6]